Anglo-Norwegian healthcare group Nycomed is evaluating the structure of its Amersham Pharmacia Biotech unit, which is 45 percent owned by Pharmacia, Reuters reported.
According to the report, Nycomed CEO Bill Castell said that the company was considering increasing its stake in APB as well as floating the unit
An announcement on the new structure is expected soon.
Meanwhile, APB said it will create about 200 new jobs, which will nearly double its workforce to 475 employees.
Most of the job openings will be in research and development at the company’s recently unveiled genomics center at its Silicon Valley-based subsidiary, Molecular Dynamics in Sunnyvale, Calif.